258 related articles for article (PubMed ID: 20454457)
1. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.
Ghoshal K; Motiwala T; Claus R; Yan P; Kutay H; Datta J; Majumder S; Bai S; Majumder A; Huang T; Plass C; Jacob ST
PLoS One; 2010 Apr; 5(4):e10338. PubMed ID: 20454457
[TBL] [Abstract][Full Text] [Related]
2. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
3. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
5. De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands.
Masalmeh RHA; Taglini F; Rubio-Ramon C; Musialik KI; Higham J; Davidson-Smith H; Kafetzopoulos I; Pawlicka KP; Finan HM; Clark R; Wills J; Finch AJ; Murphy L; Sproul D
Nat Commun; 2021 Jan; 12(1):694. PubMed ID: 33514701
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
[TBL] [Abstract][Full Text] [Related]
7. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.
Ibrahim AE; Arends MJ; Silva AL; Wyllie AH; Greger L; Ito Y; Vowler SL; Huang TH; Tavaré S; Murrell A; Brenton JD
Gut; 2011 Apr; 60(4):499-508. PubMed ID: 21068132
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
10. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.
Kanai Y; Ushijima S; Kondo Y; Nakanishi Y; Hirohashi S
Int J Cancer; 2001 Jan; 91(2):205-12. PubMed ID: 11146446
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes.
Portela A; Liz J; Nogales V; Setién F; Villanueva A; Esteller M
Oncogene; 2013 Nov; 32(47):5421-8. PubMed ID: 23686312
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
[TBL] [Abstract][Full Text] [Related]
13. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
14. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.
Datta J; Kutay H; Nasser MW; Nuovo GJ; Wang B; Majumder S; Liu CG; Volinia S; Croce CM; Schmittgen TD; Ghoshal K; Jacob ST
Cancer Res; 2008 Jul; 68(13):5049-58. PubMed ID: 18593903
[TBL] [Abstract][Full Text] [Related]
15. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
17. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues.
Velasco G; Hubé F; Rollin J; Neuillet D; Philippe C; Bouzinba-Segard H; Galvani A; Viegas-Péquignot E; Francastel C
Proc Natl Acad Sci U S A; 2010 May; 107(20):9281-6. PubMed ID: 20439742
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation regulates MicroRNA expression.
Han L; Witmer PD; Casey E; Valle D; Sukumar S
Cancer Biol Ther; 2007 Aug; 6(8):1284-8. PubMed ID: 17660710
[TBL] [Abstract][Full Text] [Related]
19. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.
Zhang B; Xiang S; Zhong Q; Yin Y; Gu L; Deng D
Hum Gene Ther; 2012 Oct; 23(10):1071-81. PubMed ID: 22738793
[TBL] [Abstract][Full Text] [Related]
20. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
